MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
12.59
-0.01 (-0.08%)
At close: May 28, 2025, 4:00 PM
12.52
-0.07 (-0.56%)
After-hours: May 28, 2025, 5:07 PM EDT
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $420.81 million as of May 28, 2025.
Market Cap
420.81M
Enterprise Value
180.16M
1-Year Change
n/a
Ranking
Category
Stock Price
12.59
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has decreased from $509.66M to $420.81M, a decrease of -17.43%. That is a compound annual growth rate of -23.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2025 | 421.15M | -31.62% |
| Dec 31, 2024 | 615.88M | 20.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.48B |
| Johnson & Johnson | 367.84B |
| AbbVie | 327.58B |
| Novo Nordisk | 313.75B |
| UnitedHealth Group | 265.08B |
| Abbott Laboratories | 231.61B |
| Novartis AG | 224.07B |
| AstraZeneca | 219.48B |